SCHEMBL2483291

SCHEMBL2483291

Cc1ccc(C(=O)O)c(O)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
HSD17B10 Q99714 2/20 0.53
HPGD P15428 1/20 0.53
SELL P14151 1/20 0.48
SELP P16109 1/20 0.48
TTR P02766 2/20 0.47
CLCN2 P51788 3/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
AKR1C2 P52895 2/20 0.45
AKR1C1 Q04828 2/20 0.45
AKR1B10 O60218 1/20 0.45
ABCB11 O95342 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
CHRM1 P11229 1/20 0.45
FABP2 P12104 1/20 0.45
RXRA P19793 1/20 0.45
TBXA2R P21731 1/20 0.45
NR4A1 P22736 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21822958 0.83 MAPT (0.38) KDM4EALDH1A1HSD17B10HPGDTTR
SCHEMBL4556197 0.83 KDM4E (0.53) KDM4EALDH1A1HSD17B10HPGDSELL
SCHEMBL109811 0.83 CLCN2 (0.49) KDM4EALDH1A1HSD17B10HPGDTTR
SCHEMBL18529852 0.82 SELL (0.56) KDM4EALDH1A1HSD17B10HPGDSELL
SCHEMBL29814908 0.81 CLCN2 (0.47) KDM4EALDH1A1HSD17B10HPGDTTR
SCHEMBL1834641 0.81 CLCN2 (0.47) KDM4EALDH1A1HSD17B10HPGDTTR
SCHEMBL30083685 0.80 ALDH1A1 (0.65) KDM4EALDH1A1HSD17B10HPGDSELL
SCHEMBL857301 0.80 ALDH1A1 (0.65) KDM4EALDH1A1HSD17B10HPGDSELL
SCHEMBL29163182 0.80 MAPK1 (0.53) KDM4EALDH1A1HSD17B10HPGDTTR
SCHEMBL9685948 0.79 CLCN2 (0.46) KDM4EALDH1A1HSD17B10HPGDTTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376428-A2 NEW INHIBITORS FOR TREATING DISEASES ASSOCIATED WITH AN EXCESS TRANSPORT OF HYALURONAN Universitätsklinikum Münster (DE) 2011-10-19 EP disclosed
WO-2010066909-A2 NEW INHIBITORS FOR TREATING DISEASES ASSOCIATED WITH AN EXCESS TRANSPORT OF HYALURONAN Universitätsklinikum Münster (DE) 2010-06-17 WO disclosed
CN-1561212-A Benzimidazolone Derivatives as Muscarinic Agents ACADIA PHARM INC (US) 2005-01-05 CN disclosed